Kintara Therapeutics Inc. sell bundfuture
Start price
01.12.22
/
50%
€8.82
Target price
01.12.23
-
Performance (%)
57.03%
End price
10.12.22
€13.85
Summary
This prediction ended on 10.12.22 with a price of €13.85. The SELL prediction by bundfuture for Kintara Therapeutics Inc. was trending in the completely wrong direction and closed with a performance of 57.03%. bundfuture has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Kintara Therapeutics Inc. | 36.296% | 36.296% | -95.678% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% |
According to bundfuture what are the pros and cons of Kintara Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by bundfuture for this prediction
In the thread Kintara Therapeutics Inc. diskutieren
Sell Kintara Therapeutics Inc.